Skip to content
Compounder
← Superinvestors

Samantha McLemore

Net selling

Patient Capital Management, LLC — managed by Samantha McLemore; US equity positions disclosed quarterly via SEC 13F

Data as of 2026-06-30 (filed 2026-08-13) · Source: SEC EDGAR

Portfolio value$3.01B (+12%)
Holdings39 (+1)
Top holdingRoyalty Pharma Plc
Below band2

New

2

Added

11

Exited

1

By what price implies: 6 demand a demanding growth rate, 9 modest.

13F × valuation

Valuation posture

Of 9 valued US positions, 2 trade below a conservative value band (as of 2026-08-25):

13F · concentration

Lonely conviction

2

Held by ≤2 tracked superinvestors, each ≥3% of this portfolio (as of 2026-06-30):

SEC 13F · latest filing

Holdings

Showing top 25 of 40 positions

Exited this quarter (1)Ishares Bitcoin Trust Etf
What is a superinvestor

About this investor

Portfolio overview

Patient Capital Management, LLC's most recent 13F filing, for the quarter ended 2026-06-30, reports 39 positions worth $3.01B. The top 5 holdings represent 31% of that value, a broadly diversified portfolio.

The single largest position is Royalty Pharma Plc at 6.7% of the portfolio, followed by Citigroup Inc at 6.5% and Alphabet Inc at 6.2%.

Against the prior quarter, Samantha McLemore opened 2 new positions, exited 1, added to 11, and trimmed 24. The largest new buy was Global Pmts Inc. The most notable sale was the full exit from Ishares Bitcoin Trust Etf.

Across all 8 quarters on file, Royalty Pharma Plc has appeared in every filing, as has Citigroup Inc. Royalty Pharma Plc currently ranks first by value.

A 13F is filed roughly 45 days after quarter-end and covers only long positions in US-listed equities, so it is a lagging and partial view of the portfolio. Source: SEC EDGAR.

Samantha McLemore has no positions in the strike zone right now. Browse the whole market by value band

Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-13

Stay Updated

New-quarter 13F moves and valuation updates, to your inbox.